Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates.

× No keyword cloud information.

10 in total

Review 1. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors: W H Bachrach; A F Hofmann
Journal: Dig Dis Sci Date: 1982-09 Impact factor: 3.199

2. Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy.

Authors: F Lammert; S Südfeld; N Busch; S Matern
Journal: World J Gastroenterol Date: 2001-04 Impact factor: 5.742

3. Metastable and equilibrium phase diagrams of unconjugated bilirubin IXα as functions of pH in model bile systems: Implications for pigment gallstone formation.

Authors: Marvin D Berman; Martin C Carey
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-10-30 Impact factor: 4.052

4. Dissolution of cholesterol gallstones by bile acids in the prairie dog.

Authors: B I Cohen; E H Mosbach; S Kuroki; C K McSherry
Journal: Lipids Date: 1988-03 Impact factor: 1.880

5. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.

Authors: H Igimi; S Asakawa; D Watanabe; H Shimura
Journal: Gastroenterol Jpn Date: 1983-04

6. Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.

Authors: K von Bergmann; A Beck; C Engel; O Leiss
Journal: Klin Wochenschr Date: 1987-05-15

7. Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.

Authors: U K Jain; W I Higuchi; C L Liu; P H Lee; N A Mazer
Journal: Pharm Res Date: 1992-06 Impact factor: 4.200

Review 8. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors: A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1984-02 Impact factor: 9.546

9. Tauroursodeoxycholic acid is less damaging than taurochenodeoxycholic acid to the gastric and esophageal mucosa.

Authors: K D Lillemoe; G W Kidder; J W Harmon; T R Gadacz; L F Johnson; R M Bunte; A F Hofmann
Journal: Dig Dis Sci Date: 1983-04 Impact factor: 3.199

10. Evidence for distinct precursor pools for biliary cholesterol and primary bile acids in cebus and cynomolgus monkeys.

Authors: Z F Stephan; K C Hayes
Journal: Lipids Date: 1985-06 Impact factor: 1.880

10 in total